But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

Pfizer has decided to halt the development of its potential once-daily pill treatment for obesity due to safety concerns before advancing to later stages of clinical testing.

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

A diverse range of medical specialists offer unique expertise for obesity treatment. “Endocrinologists, bariatricians, obesity specialists and psychiatrists can prescribe weight loss medication,” ...

Donald Trump's tariff war may threaten the supply of blockbuster weight loss jabs relied on by millions ... make it harder for patients to access treatment, causing frustration, anxiety and ...

Its approach is designed by a top team of experts in nutrition, behavioural change, digital health, and medicine, helping thousands transform their lifestyles to lose weight and improve wellbeing.

shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss experienced minimal lean muscle mass loss as they lost weight across six months of treatment.

If you approach weight loss with a short-term attitude, you may not make it anywhere except on the yo-yo diet train. Part of successful, sustainable weight loss — losing the weight and keeping ...

The traditional diet of restricting calories is a tried-and-true method for weight loss — but new research reveals that a certain intermittent fasting regimen may be more effective. Researchers ...

BT: What is the expected timeline for the launch of Ozempic in India ... semaglutide has shown proven benefits for obesity treatment. Obesity management goes beyond weight loss — it is key to reducing ...